PTPN11 mutations are associated with poor outcomes across myeloid malignancies.
Swoboda DM, Ali NA, Chan O, Padron E, Kuykendall AT, Song J, Hussaini M, Talati C, Sweet K, Lancet JE, Sallman DA, Komrokji RS.
Swoboda DM, et al. Among authors: chan o.
Leukemia. 2021 Jan;35(1):286-288. doi: 10.1038/s41375-020-01083-3. Epub 2020 Nov 1.
Leukemia. 2021.
PMID: 33132383
No abstract available.